Press Releases July 3, 2026 04:30 PM

Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08

Teladoc Health grants inducement award of restricted stock units to new Head of Product for BetterHelp under NYSE rules.

By Priya Menon
Share
Twitter Reddit Facebook LinkedIn
TDOC

Teladoc Health announced the issuance of an inducement award consisting of 50,000 restricted stock units to David Packles, the new Head of Product for its BetterHelp division. This award is designed to incentivize his employment and vests over three years. The award was granted in compliance with NYSE Rule 303A.08 and approved by the company's Compensation Committee.

Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08
TDOC
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Teladoc Health hired David Packles as Head of Product for BetterHelp and issued 50,000 restricted stock units as inducement.
  • The RSUs vest over three years, aligning Packles’ interests with company performance.
  • The grant follows NYSE regulations for inducement awards and was approved by the Compensation Committee.

NEW YORK, July 03, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today announced that it issued an inducement award to a new employee.

Effective July 1, 2026, in connection with commencing employment as Head of Product of BetterHelp, David Packles was granted an award of restricted stock units covering 50,000 shares of Teladoc Health’s common stock, par value $0.001 per share (“Common Stock”). The restricted stock units vest, based on continued service to Teladoc Health, as to one-third of the underlying shares on the first anniversary of the grant date, with the remainder vesting quarterly over two years thereafter. The award was approved by the Compensation Committee of the Board of Directors of Teladoc Health and was granted under the Teladoc Health, Inc. 2023 Employment Inducement Incentive Award Plan as an employment inducement award pursuant to New York Stock Exchange Rule 303A.08.

About Teladoc Health
Teladoc Health (NYSE: TDOC) is the global leader in virtual care. The company is delivering and orchestrating care across patients, care providers, platforms, and partners — transforming virtual care into a catalyst for how better health happens. Through our relationships with health plans, employers, providers, health systems and consumers, we are enabling more access, driving better outcomes, extending provider capacity and lowering costs. Learn more at teladochealth.com.

Media:
Lou Serio
202-569-9715
[email protected]


Risks

  • The value of the inducement award depends on Teladoc Health’s stock price and company performance, exposing the company to equity dilution risks.
  • Uncertainty if the new executive appointment will achieve desired product leadership impact on BetterHelp’s performance and growth.
  • Market or regulatory changes in the virtual healthcare sector could affect Teladoc’s operational and financial outcomes.

More from Press Releases

Inter&Co Delivers Record 3Q26 Net Income of US$76.1 Million, With Strong Growth, Higher Margin and Better Efficiency Nov 12, 2026 Super League to Report Third Quarter 2026 Financial Results on Monday, November 16, 2026 Nov 12, 2026 UroGen Reports $68.0 Million of ZUSDURI Revenue and Provides Third Quarter 2026 Financial Results and Highlights Nov 4, 2026 BioVie Announces Pricing of $4.74 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules Nov 4, 2026 Jasper Therapeutics Announces 1-for-30 Reverse Stock Split Nov 4, 2026